Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Different Treatment Options on Markers of Vascular, Myocardial and Endothelial Function in Women With Polycystic Ovary Syndrome and the Association With Metabolic and Hormonal Abnormalities of the Syndrome

NCT06889454 is registered in ClinicalTrials.gov with Attikon Hospital as lead sponsor.

NCT NCT06889454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06889454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Different Treatment Options on Markers of Vascular, Myocardial and Endothelial Function in Women With Polycystic Ovary Syndrome and the Association With Metabolic and Hormonal Abnormalities of the Syndrome
Lead sponsor
Attikon Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2024
Completion date
February 1, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperandrogenism, hyperinsulinism, metabolic syndrome, pcos